271 related articles for article (PubMed ID: 19394183)
1. High spatial resolution magnetic resonance imaging of experimental cerebral venous thrombosis with a blood pool contrast agent.
Spuentrup E; Wiethoff AJ; Parsons EC; Spangenberg P; Stracke CP
Eur J Radiol; 2010 Jun; 74(3):445-52. PubMed ID: 19394183
[TBL] [Abstract][Full Text] [Related]
2. High spatial resolution and high contrast visualization of brain arteries and veins: impact of blood pool contrast agent and water-selective excitation imaging at 3T.
Spuentrup E; Jacobs JE; Kleimann JF; Wiethoff AJ; Poggenborg J; Brinker G; Loehr M; Möller-Hartmann W; Botnar RM; Ernestus RI; Lackner KJ
Rofo; 2010 Dec; 182(12):1097-104. PubMed ID: 20803412
[TBL] [Abstract][Full Text] [Related]
3. The value of T2*-weighted gradient-echo MRI for the diagnosis of cerebral venous sinus thrombosis.
Ihn YK; Jung WS; Hwang SS
Clin Imaging; 2013; 37(3):446-50. PubMed ID: 23068055
[TBL] [Abstract][Full Text] [Related]
4. Absolute quantification of regional renal blood flow in swine by dynamic contrast-enhanced magnetic resonance imaging using a blood pool contrast agent.
Lüdemann L; Nafz B; Elsner F; Grosse-Siestrup C; Meissler M; Kaufels N; Rehbein H; Persson PB; Michaely HJ; Lengsfeld P; Voth M; Gutberlet M
Invest Radiol; 2009 Mar; 44(3):125-34. PubMed ID: 19151609
[TBL] [Abstract][Full Text] [Related]
5. Molecular MRI of cerebral venous sinus thrombosis using a new fibrin-specific MR contrast agent.
Stracke CP; Katoh M; Wiethoff AJ; Parsons EC; Spangenberg P; Spüntrup E
Stroke; 2007 May; 38(5):1476-81. PubMed ID: 17379818
[TBL] [Abstract][Full Text] [Related]
6. Comparison of gadofosveset trisodium and gadobenate dimeglumine during time-resolved thoracic MR angiography at 3T.
Frydrychowicz A; Russe MF; Bock J; Stalder AF; Bley TA; Harloff A; Markl M
Acad Radiol; 2010 Nov; 17(11):1394-400. PubMed ID: 20650665
[TBL] [Abstract][Full Text] [Related]
7. Visualization of deep veins and detection of deep vein thrombosis (DVT) with balanced turbo field echo (b-TFE) and contrast-enhanced T1 fast field echo (CE-FFE) using a blood pool agent (BPA).
Enden T; Storås TH; Negård A; Haig Y; Sandvik L; Gjesdal KI; Sandset PM; Kløw NE
J Magn Reson Imaging; 2010 Feb; 31(2):416-24. PubMed ID: 20099355
[TBL] [Abstract][Full Text] [Related]
8. Molecular magnetic resonance imaging of deep vein thrombosis using a fibrin-targeted contrast agent: a feasibility study.
Katoh M; Haage P; Wiethoff AJ; Günther RW; Bücker A; Tacke J; Spuentrup E
Invest Radiol; 2009 Mar; 44(3):146-50. PubMed ID: 19151606
[TBL] [Abstract][Full Text] [Related]
9. Molecular coronary MR imaging of human thrombi using EP-2104R, a fibrin-targeted contrast agent: experimental study in a swine model.
Spuentrup E; Katoh M; Wiethoff AJ; Buecker A; Botnar RM; Parsons EC; Guenther RW
Rofo; 2007 Nov; 179(11):1166-73. PubMed ID: 17948194
[TBL] [Abstract][Full Text] [Related]
10. [Magnetic resonance angiography with gadolinium (Gd-DTPA) versus baseline magnetic resonance angiography in the study of the intracranial circulation].
Tartaro A; Severini S; Tonni G; Magarelli N; Carriero A; Bonomo L
Radiol Med; 1992 Nov; 84(5):536-43. PubMed ID: 1475415
[TBL] [Abstract][Full Text] [Related]
11. Cerebral MR venography in children: comparison of 2D time-of-flight and gadolinium-enhanced 3D gradient-echo techniques.
Rollins N; Ison C; Reyes T; Chia J
Radiology; 2005 Jun; 235(3):1011-7. PubMed ID: 15860678
[TBL] [Abstract][Full Text] [Related]
12. Gadofosveset trisodium-enhanced magnetic resonance angiography of the left atrium--a feasibility study.
Wagner M; Rief M; Asbach P; Vogtmann T; Huppertz A; Beling M; Butler C; Laule M; Warmuth C; Taupitz M; Hamm B; Lembcke A
Eur J Radiol; 2010 Aug; 75(2):166-72. PubMed ID: 19464133
[TBL] [Abstract][Full Text] [Related]
13. Importance of T2*-weighted gradient-echo MRI for diagnosis of cortical vein thrombosis.
Fellner FA; Fellner C; Aichner FT; Mölzer G
Eur J Radiol; 2005 Nov; 56(2):235-9. PubMed ID: 15967621
[TBL] [Abstract][Full Text] [Related]
14. Three-dimensional cerebral contrast-enhanced magnetic resonance venography at 3.0 Tesla: initial results using highly accelerated parallel acquisition.
Nael K; Fenchel M; Salamon N; Duckwiler GR; Laub G; Finn JP; Villablanca JP
Invest Radiol; 2006 Oct; 41(10):763-8. PubMed ID: 16971800
[TBL] [Abstract][Full Text] [Related]
15. Congenital heart disease: cardiovascular MR imaging by using an intravascular blood pool contrast agent.
Makowski MR; Wiethoff AJ; Uribe S; Parish V; Botnar RM; Bell A; Kiesewetter C; Beerbaum P; Jansen CH; Razavi R; Schaeffter T; Greil GF
Radiology; 2011 Sep; 260(3):680-8. PubMed ID: 21613441
[TBL] [Abstract][Full Text] [Related]
16. 4D phase contrast MRI at 3 T: effect of standard and blood-pool contrast agents on SNR, PC-MRA, and blood flow visualization.
Bock J; Frydrychowicz A; Stalder AF; Bley TA; Burkhardt H; Hennig J; Markl M
Magn Reson Med; 2010 Feb; 63(2):330-8. PubMed ID: 20024953
[TBL] [Abstract][Full Text] [Related]
17. Contrast-enhanced MR angiography for the diagnosis of intracranial vascular disease: optimal dose of gadopentetate dimeglumine.
Jung HW; Chang KH; Choi DS; Han MH; Han MC
AJR Am J Roentgenol; 1995 Nov; 165(5):1251-5. PubMed ID: 7572513
[TBL] [Abstract][Full Text] [Related]
18. Improved characterization of popliteal aneurysms using gadofosveset-enhanced equilibrium phase magnetic resonance angiography.
Galizia MS; Ward E; Rodriguez H; Collins J; Carr J
J Vasc Surg; 2013 Mar; 57(3):837-41. PubMed ID: 23294506
[TBL] [Abstract][Full Text] [Related]
19. Biphasic blood pool contrast agent-enhanced whole-body MR angiography for treatment planning in patients with significant arterial stenosis.
Huppertz A; Kroll H; Klessen C; Taupitz M; Rückert RI; Schröder RJ; Albrecht T; Frericks B; Voth M; Wagner M; Hamm B; Asbach P
Invest Radiol; 2009 Jul; 44(7):422-32. PubMed ID: 19448555
[TBL] [Abstract][Full Text] [Related]
20. Cardiac magnetic resonance angiography using blood-pool contrast agents: comparison of citrate-coated very small superparamagnetic iron oxide particles with gadofosveset trisodium in pigs.
Schnorr J; Taupitz M; Schellenberger EA; Warmuth C; Fahlenkamp UL; Wagner S; Kaufels N; Wagner M
Rofo; 2012 Feb; 184(2):105-12. PubMed ID: 22179768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
